ClinicalTrials.gov
public full text
Public Domain
A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI
This is a first-in-human (FIH), Phase 1b, open-label, dose-escalation, safety trial consisting of 3 dose levels. Subjects will always be treated in cohorts of size 3, with from 3 up to 6 cohorts i.e. 9-18 subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ivacaftor Treatment in 4 Month to 2 Year Old CF Subjects#1173108
- Anti-Müllerian Hormone and Embryo Aneuploidy#810996
- VITAL - Individualising Therapy for Neovascular AMD With Aflibercept#847166
- Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants#878541
- TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas#880258
Record · ID 911986
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive